Nektar closes direct private placement with TPG Special Situations Partners
Nektar Therapeutics announced the closing of a direct private placement of $250 million of 7.75% Senior Secured Notes Due in 2020 with investment vehicles managed by affiliates of TPG Special Situations Partners. October 06, 2015